Rog Eb News Today

By Adria Calatayud Roche Holding is scheduled to report results for 2023 on Thursday. Here is what you need to know. SALES FORECAST: The Swiss pharmaceutical...

ARK Innovation and other actively managed ETFs are having a banner year. Picking winners is as tricky as ever.

Drugmaker is doubling down on cancer and neurology as it seeks to replace falling revenue from its top sellers

Biotech deals are heating up as the year comes to an end, and analysts say the hot streak will likely continue in coming months. AbbVie and Roche Holding...

By Andrea Figueras Roche said it obtained positive results for its investigational treatment, inavolisib, as a first-line treatment for people with breast...

By Andrea Figueras Roche said that it has received positive long-term follow-up data and significant overall survival benefit from the Katherine study, which...

By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing...

By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The...

Supreme Court case puts focus on wealth taxes, IBM and Meta form group to support open approach to AI, more pharmas seek a stake in weight-loss market, and...

Pfizer expects the market for new obesity pills to be $90 billion per year. Lilly, Novo, and many biotechs hope to claim chunks of it.